ORMP - ORAMED PHARMACEUTICALS INC.
2.22
-0.010 -0.450%
Share volume: 27,719
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.23
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-10-2023 | 11-09-2023 | 11-07-2024 | 05-09-2024 | 08-14-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 666.000 K | 674.000 K | 663.000 K | 287.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 666.000 K | 674.000 K | 663.000 K | 287.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| 1.20% | -1.63% | -56.71% | -100.00% | nan% | nan% | nan% | |||
| Operating expenses | 5.690 M | 4.273 M | 3.556 M | 3.877 M | 2.962 M | 3.135 M | 3.089 M | 3.595 M | |
| Selling general and admin | 1.263 M | 2.452 M | 2.599 M | 2.111 M | 1.783 M | 1.693 M | 847.000 K | 2.134 M | |
| Research and development | 4.427 M | 1.821 M | 957.000 K | 1.766 M | 1.179 M | 1.442 M | 2.242 M | 1.461 M | |
| Total expenses | 5.874 M | 4.465 M | 3.556 M | 4.164 M | 2.962 M | 3.135 M | 3.089 M | 3.595 M | |
| -23.99% | -20.36% | 17.10% | -28.87% | 5.84% | -1.47% | 16.38% | |||
| Operating income | -5.208 M | -3.791 M | -2.893 M | -3.877 M | -2.962 M | -3.135 M | -3.089 M | -3.595 M | |
| Ebit | -3.611 M | -1.313 M | -2.458 M | 14.507 M | 2.126 M | 11.099 M | -18.509 M | -9.783 M | |
| Pretax income | -3.611 M | -1.313 M | -3.284 M | 13.296 M | 1.534 M | 10.838 M | -18.509 M | -9.783 M | |
| -63.64% | 150.11% | -504.87% | -88.46% | 606.52% | -270.78% | -47.14% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.634 M | 1.133 M | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -3.611 M | -1.313 M | -3.284 M | 13.296 M | 1.534 M | 9.204 M | -19.642 M | -10.156 M | |
| 63.64% | -150.11% | 504.87% | -88.46% | 500.00% | -313.41% | 48.29% |
